OpenAI CEO Sam Altman’s secretive longevity startup, Retro Biosciences, is making waves in the anti-aging space with plans to launch its first commercial product as early as 2025. The company, which received a staggering $180 million investment from Altman, is developing a brain-focused supplement designed to enhance cognitive function and potentially extend human healthspan. This move represents one of the first tangible consumer products to emerge from the billionaire’s ambitious longevity investments, signaling a shift from theoretical research to practical applications in the anti-aging market.
According to Business Insider reports, Retro Biosciences has been operating largely under the radar while building a team of over 50 scientists focused on extending healthy human lifespan by 10 years. The company’s approach combines AI-driven research with traditional biotechnology to target the fundamental mechanisms of aging. While specific details about the brain pill’s formulation remain confidential, sources suggest it may incorporate compounds that address neuroinflammation and support cellular regeneration—key factors in cognitive decline associated with aging. This development comes amid growing interest in longevity tech from Silicon Valley’s elite, with Altman joining figures like Jeff Bezos and Peter Thiel in backing ambitious anti-aging ventures.
The timing of this announcement coincides with explosive growth in the global longevity market, projected to reach $64 billion by 2026. Retro’s entry into the consumer space with a brain-focused supplement strategically positions the company at the intersection of two booming industries: cognitive enhancement and anti-aging technology. However, the product will likely face scrutiny from regulators and the scientific community regarding efficacy claims and long-term safety. As Retro Biosciences prepares for this commercial launch, the move highlights how AI leaders are increasingly leveraging their technological expertise and capital to disrupt healthcare and potentially reshape human longevity.